Thoroughbred Financial Services’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,733
| Closed | -$611K | – | 714 |
|
|
2025
Q1 | $611K | Sell |
2,733
-14
| -0.5% | -$3.13K | 0.04% | 377 |
|
|
2024
Q4 | $899K | Sell |
2,747
-149
| -5% | -$48.8K | 0.05% | 295 |
|
|
2024
Q3 | $869K | Buy |
2,896
+220
| +8% | +$66K | 0.06% | 303 |
|
|
2024
Q2 | $881K | Buy |
2,676
+2,036
| +318% | +$670K | 0.06% | 287 |
|
|
2024
Q1 | $253K | Sell |
640
-2,103
| -77% | -$831K | 0.02% | 405 |
|
|
2023
Q4 | $965K | Sell |
2,743
-39
| -1% | -$13.7K | 0.08% | 245 |
|
|
2023
Q3 | $1.04M | Buy |
2,782
+2,142
| +335% | +$803K | 0.1% | 203 |
|
|
2023
Q2 | $244K | Hold |
640
| – | – | 0.03% | 360 |
|
|
2023
Q1 | $221K | Buy |
+640
| New | +$221K | 0.03% | 377 |
|
|
2022
Q3 | – | Sell |
-860
| Closed | -$260K | – | 388 |
|
|
2022
Q2 | $260K | Sell |
860
-55
| -6% | -$16.6K | 0.05% | 311 |
|
|
2022
Q1 | $375K | Buy |
+915
| New | +$375K | 0.06% | 259 |
|